Anders Bengtsson
111 – 120 of 206
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Total cost and cost predictors in systemic lupus erythematosus - 8-years follow-up of a Swedish inception cohort.
- Contribution to journal › Article
-
Mark
A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa.
- Contribution to journal › Article
-
Mark
A subset of patients with systemic lupus erythematosus fails to degrade DNA from multiple clinically relevant sources.
- Contribution to journal › Article
-
Mark
Incidence and disease severity of anti-neutrophil cytoplasmic antibody-associated nephritis are higher than in lupus nephritis in Sweden.
- Contribution to journal › Article
- 2014
-
Mark
Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
- Contribution to journal › Article
-
Mark
Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study.
- Contribution to journal › Article
-
Mark
Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization.
- Contribution to journal › Article
-
Mark
Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus
- Contribution to journal › Article
-
Mark
Multiplexing of miniaturized planar antibody arrays for serum protein profiling - a biomarker discovery in SLE nephritis.
- Contribution to journal › Article
-
Mark
Belimumab in systemic lupus erythematosus -- what can be learned from longterm observational studies?
- Contribution to journal › Debate/Note/Editorial
